Vitamin B-12 deficiency is present in up to 15% of the elderly populat
ion as documented by elevated methylmalonic acid with or without eleva
ted total homocysteine concentrations in combination with low or low-n
ormal vitamin B-12 concentrations. Clinical signs and symptoms of vita
min B-12 deficiency are insensitive in elderly subjects and comorbidit
y in these subjects makes responses to therapy difficult to interpret.
Many elderly subjects with hyperhomocysteinemia have undiagnosed vita
min B-12 deficiency with elevated serum methylmalonic acid concentrati
ons. Therefore, such elderly subjects should not receive folic acid su
pplementation before their vitamin B-12 status is diagnosed. Oral vita
min B-12 supplementation may be effective in lowering serum methylmalo
nic acid values in the elderly. However, the dose of vitamin B-12 in m
ost common multivitamin preparations is too low for this purpose. Rese
arch efforts should be directed toward determining practical methods f
or diagnosing and treating vitamin B-12 deficiency in the millions of
elderly subjects with undiagnosed deficiency.